Patent pending. Clinical validation in development.
NUWAC.COM

RESEARCH + VALIDATION

Evidence is not an afterthought.
It is part of the architecture.

NUWAC is being developed so each configured session can produce an interpretable trace—connecting clinical intent, movement events, feedback, and response.

Follow the evidence path
NUWAC / VALIDATIONRESEARCH-STAGE · CLINICAL VALIDATION IN DEVELOPMENT
01 / VALIDATION LOGIC

A claim should follow a trace.

The validation strategy begins with defined protocols and structured session outputs—not invented statistics or unsupported outcomes.

01

Define the intended context

Specify the research question, population, protocol, and measurable movement objective before interpreting results.

02

Calibrate the session

Establish patient-specific and session-specific context so movement events are not treated as context-free numbers.

03

Preserve what happened

Record relevant sensing, decision, feedback, and continuity events as a structured session trace.

04

Review the relationship

Examine the connection between configured intent, detected movement, delivered feedback, and subsequent response.

05

Build evidence progressively

Use well-defined studies and partnerships to evaluate feasibility, usability, measurement quality, and clinical relevance.

02 / STRUCTURED OUTPUTS

From session events to candidate biomarkers.

The platform architecture is intended to support repeatable, reviewable outputs. Candidate biomarkers remain subject to research and clinical validation.

Temporal movement traces

Organized timing and event relationships across the configured session.

Loading relationships

Structured patterns derived from wearable pressure sensing within the study context.

Response trajectories

Relationships between configured feedback events and subsequent movement signals.

Session progression

Comparable outputs designed to support longitudinal review across repeated sessions.

Continuity events

Connection, recovery, and session-state events preserved for interpretability.

Research-ready outputs

Structured exports intended for transparent analysis and collaboration.

03 / EVIDENCE ROADMAP

Validation advances in defined steps.

The sequence below describes a development direction, not completed clinical evidence.

Stage 01

Engineering verification

Confirm sensing, feedback, timing, session continuity, and data integrity against defined technical requirements.

Stage 02

Feasibility + usability

Evaluate whether clinicians and participants can understand, configure, and use the workflow as intended.

Stage 03

Measurement studies

Assess repeatability, agreement, sensitivity, and the interpretability of candidate movement outputs.

Stage 04

Clinical partnerships

Develop condition-specific protocols with research and rehabilitation partners under appropriate oversight.

Stage 05

Progressive clinical validation

Evaluate defined outcomes for specific applications before making condition-specific performance claims.

04 / RESEARCH PARTNERSHIPS

Build the evidence with us.

NUWAC is seeking serious clinical and academic collaborators interested in gait measurement, biofeedback, rehabilitation workflows, and digital biomarker development.

Register research interest
01Clinician-informed protocol design
02Transparent research outputs
03Defined study questions and boundaries
04No unsupported public claims